Delivery Order SPE2DR25D1100-SPE2DR26FDE7J
Award Date 2/11/26
Potential Completion Date 2/12/26
Potential Value $3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $24,210.09 delivery order to AmerisourceBergen Drug Corp on February 11, 2026, for supply of Rexulti 1 mg tablets (30-count). The order is issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which supports global pharmaceutical supply to military healthcare programs. Place of performance is Conshohocken, PA. The order has a firm fixed price structure with an ultimate...
- <p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 11, 2026, for Rexulti 2 mg tablets (30 count), with a ceiling value of $11,513.66.</p> <p>Place of performance is Conshohocken, PA. The order has a firm fixed price structure and an ultimate completion date of February 12, 2026. This delivery order was issued without a set-aside under the parent indefinite delivery contract with DLA Troop Support Medical.</p>
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Rexulti 1 mg tablets (30-count) at a ceiling value of $5,400.39. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procedures. The contract is scheduled for ultimate completion on November 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 23, 2026, for the supply of Rexulti 3 mg tablets in a quantity of 30 units, with a ceiling value of $1,472.28. This is a firm fixed-price delivery order with no set-aside designation, meaning the award was competitively procured on a full and open basis. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and the delivery order is scheduled for...
- This $10,959.63 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets. The order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. AmerisourceBergen, a major pharmaceutical distributor, is the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Rexulti 2 mg tablets (30-count packages) with a ceiling value of $9,967.07. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 8, 2025, and will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating open competition among qualified...
- The Defense Logistics Agency awarded a delivery order valued at $7,691.76 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count package). This competitively awarded, firm fixed-price delivery order was issued on December 30, 2025, with an ultimate completion date of December 31, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Rexulti 2 mg tablets in a quantity of 30 units, with a ceiling value of $3,228.07. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for ultimate completion by July 24, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is issued...
- The Defense Logistics Agency awarded a Delivery Order valued at $2,783.93 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The order represents a single transaction under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $5,225.26 to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Rexulti 2 mg tablets (30-count units). This is a firm fixed-price delivery order with no set-aside designation, issued competitively under the company's existing indefinite delivery contract with DLA. The order is scheduled for completion by January 6, 2026, and will be fulfilled from AmerisourceBergen's corporate headquarters location in Conshohocken,...